EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparing 6-Year Carbon Footprint Between GINA Track 1 and 2 Asthma Management for Adults: A Real-World Primary Care Report from Singapore to Advocate for Policy Change in Inhaler Procurement

Ngiap Chuan Tan iD, Ding Xuan Ng iD, Mabel Qi He Leow iD, Yi Ling Eileen Koh iD

Journal of Primary Care & Community Health · 2026

DOI: 10.1177/21501319251411430 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Primary Care & Community Health, 2026. Verfasst von Ngiap Chuan Tan und 3 weiteren Autor:innen. Beteiligte Einrichtung: SingHealth Polyclinics, Singapore. Hauptthemen laut MEDLINE: Asthma, Carbon Footprint, Budesonide, Formoterol Fumarate Drug Combination, Anti-Asthmatic Agents. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SingHealth Polyclinics – Centre Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Global Initiative for Asthma (GINA) has recommended inhaled corticosteroid (ICS)-Formoterol as Track-1 treatment for patients. Using ICS and SABA (Short-Acting Beta-Agonist) as a reliever is an alternative Track-2 option. Both modalities are tied to type of inhaler use, dry powder inhalers (DPI) and propellent-containing metered-dose inhalers (pMDI). Compared to propellent-free DPI, pMDI have much higher carbon footprint (CF) detrimental to the environment. Leveraging on dispensed inhaler data from the electronic medical records of patients managed in primary care, the study aimed to quantify their CF using Budesonide-Formoterol (BUD-FOR) DPI alone, compared to those who were treated with BUD-FOR DPI + pMDI as a reliever.

Methods

Electronic medical records from 8 public primary care clinics were analysed, covering adult asthma patients (aged ≥21) between 2018 and 2023. Data on inhaler dispensing, asthma control test (ACT) scores and rescue therapy (RT) needs were assessed. CF was computed based on inhaler canisters dispensed. Associations between treatment modality, asthma control, RT and CF were analysed using Generalized Estimating Equations.

Results

A total of 5634 patients using BUD-FOR DPI were included. Over the study period, Track-1 usage increased substantially from 466 to 2317 patients, while Track-2 rose modestly from 628 to 758. In 2023, 78.5% of patients achieved good asthma control compared to 68.7% in Track-2. The total CF per patient was substantially lower in Track-1 compared to Track-2 (3.3 vs 62.4 kgCO₂e). Patients in Track-1 had a significantly lower CF by 60 kgCO₂e ( P < .001), had 1.5 times higher odds to achieve good asthma control based on ACT scores ( P < .001) and had approximately 30% lower odds of receiving RT ( P < .001). The average number of SABA-pMDI canisters dispensed per patient declined from 2.8 to 2.1 over the study period. BUD/FOR inhalers use per patient per year was consistently higher in Track 2 compared to Track 1, with an average difference of 1.2 canisters (5.3 vs 4.1).

Conclusion

Patients managed under Track-1 treatment approach demonstrated significantly better asthma outcomes and lower CF. These findings highlight potential of Track-1 treatment as the preferred strategy, enabling better clinical outcomes and reduced environmental impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaCarbon FootprintBudesonide, Formoterol Fumarate Drug CombinationAnti-Asthmatic AgentsHumansPrimary Health CareAdultDry Powder InhalersFemaleMiddle AgedSingaporeMaleMetered Dose InhalersAdministration, InhalationAdrenal Cortex HormonesBronchodilator Agents

Stichwörter der Autor:innen

MARTcarbon footprintdry powdered inhalerpropellent-containing metered dose inhaler

Substanzen

Adrenal Cortex HormonesBudesonide, Formoterol Fumarate Drug CombinationBronchodilator AgentsAnti-Asthmatic Agents

Autor:innen und Institutionen

  • SingHealth Polyclinics, Singapore.
  • Duke-NUS Medical School, Singapore.

ORCID-Profile: Ngiap Chuan Tan, Ding Xuan Ng, Mabel Qi He Leow, Yi Ling Eileen Koh

Förderung

  • SingHealth Polyclinics – Centre Grant

Zitieren

APA

Tan, N. C., Ng, D. X., Leow, M. Q. H., & Koh, Y. L. E. (2026). Comparing 6-Year Carbon Footprint Between GINA Track 1 and 2 Asthma Management for Adults: A Real-World Primary Care Report from Singapore to Advocate for Policy Change in Inhaler Procurement. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319251411430

Vancouver

Tan NC, Ng DX, Leow MQH, Koh YLE. Comparing 6-Year Carbon Footprint Between GINA Track 1 and 2 Asthma Management for Adults: A Real-World Primary Care Report from Singapore to Advocate for Policy Change in Inhaler Procurement. Journal of Primary Care & Community Health. 2026. doi:10.1177/21501319251411430

BibTeX
@article{Tan2026,
  author = {Tan, Ngiap Chuan and Ng, Ding Xuan and Leow, Mabel Qi He and Koh, Yi Ling Eileen},
  title = {Comparing 6-Year Carbon Footprint Between GINA Track 1 and 2 Asthma Management for Adults: A Real-World Primary Care Report from Singapore to Advocate for Policy Change in Inhaler Procurement},
  journal = {Journal of Primary Care & Community Health},
  year = {2026},
  doi = {10.1177/21501319251411430}
}
Kostenlos starten →